Science – Innovation – Value
CTC Advisory Board
Book a free 2-hour consultation with CTC’s advisory board.
You will meet a team of experts in early phase clinical development and clinical pharmacology handpicked to address your specific questions and needs. The team will provide customised advice to optimise your molecule’s path from the first-in-human trial to Phase IIa with subsequent phases in mind.
The core of CTC’s advisory board consists of:
- Bengt Dahlström, founder of CTC and senior scientific advisor
- Johan Bylund, DMPK specialist and senior scientific advisor
- Sandra Kuusk, Chief Scientific Officer
- Helena Litorp, Chief Medical Officer
- Fredrik Hansson, senior statistical advisor
For each meeting, we will supplement the core team with specialists relevant for the meeting agenda. Besides our experienced in-house full-time physicians, we have access to a large pool of medical experts within various therapeutic areas. In addition, we have the possibility to invite experts from our sister companies within Center for Translational research: RegSmart Life Science AB, Toxicology Knowledge Team (TKT) and Lablytica Life Science AB.
Meeting output (examples)
- Important key elements to consider before the start of your trial
- Input on your preliminary study design
- Estimated cost (ballpark)
Before your scheduled visit, both parts will sign a CDA to enable a transparent discussion.
Send a request for a free 2-hour meeting
We translate science into treatment
Clinical Trial Consultants is a full-service CRO with focus on clinical conduct at our own research facilities, a first-in-human approved unit at Uppsala University Hospital (12 beds) and a phase I-II unit (24 beds) in Science Park, Uppsala. We have a long experience within clinical trials in early phase, from first-in-human to proof-of-concept. We offer a package deal including all key elements from advice of study design and protocol writing to the clinical conduct at own research units and/or multicenter trials, project management as well as biostatistics and report writing. We also have a well-established pharmacovigilance department with medical monitoring and reporting of adverse events as well as a patient recruitment team specialized in recruiting healthy volunteers and patient populations.
CTC started in 2011 and has since then successfully conducted over 350 industry sponsored clinical trials for startups, international pharmaceutical and MedTech companies, and CROs.